医学
连续血糖监测
2型糖尿病
1型糖尿病
重症监护医学
糖尿病
胰岛素
内科学
内分泌学
作者
Banshi Saboo,Ranjit Unnikrishnan,Jothydev Kesavadev,Mangesh Tiwaskar,Leszek Czupryniak,Manoj Chawla,Pratik Choudhary,Tadej Battelino,Sanjay Agarwal,Thomas Danne,Viswanathan Mohan
出处
期刊:PubMed
日期:2023-06-01
卷期号:71 (6): 11-12
被引量:2
标识
DOI:10.5005/japi-11001-0274
摘要
To suggest how continuous glucose monitoring (CGM) may be used intermittently in individuals with type 2 diabetes (T2D).The use of CGM is largely in those with type 1 diabetes (T1D), in whom it makes sense to use CGM continuously as CGM provides a valuable tool to not only adjust their insulin doses but also to match it with their diet, physical activity, and other lifestyle modifications. In the case of T2D, however, especially for those not on insulin, the use of CGM may not be needed on a continuous basis. The use of CGM on an intermittent basis is rarely discussed in the literature. This article tries to provide clinical situations where CGM can be used intermittently.Intermittent use of CGM defined as the "use of CGM once in 2 or 3 months or a fixed frequency," and may be useful in several situations in those with T2D. We suggest the following indications for the intermittent use of CGM in T2D-newly diagnosed patients where treatment is being started, uncontrolled diabetes where treatment is being altered, starting intensive lifestyle modification, during infections, during preoperative control, in children and adolescents with T2D, as a motivational tool to improve behavioral modification, after metabolic surgery, and in patients on steroids, apart from other indications.Intermittent use of CGM in T2D can be useful in special situations and can also be cost saving particularly in resource-constrained regions of the world.
科研通智能强力驱动
Strongly Powered by AbleSci AI